iSpecimen Inc. (ISPC): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
iSpecimen Inc. (ISPC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers. Departure of Chief Executive Officer On August 26, 2026, Katharyn Field informed the Board of Directors (the “Board”) of iSpecimen Inc. (the “Company”) of her decision t
How this was made
The 30-second read
Why it matters
The filing provides the first public disclosure of the CEO change, a material corporate event for the company.
Market read
Executive transition may influence stock volatility and investor perception.
What to watch
contractor structure limits benefits and may affect long‑term retention
Background
SEC Form 8‑K filing detailing executive turnover at iSpecimen Inc.
Ticker impact
SEC 8‑K reports CEO Katharyn Field's departure and appointment of Shahin Behroyan as new CEO effective immediately.
potential short‑term volatility with no clear directional bias
New CEO appointed via independent contractor agreement; compensation disclosed, but no operational changes yet.
Market effects
minimal impact on broader sector; leadership change specific to iSpecimen
none
none
Counterpoint
new CEO may accelerate growth initiatives, offering upside if execution succeeds
Key entities
- companyiSpecimen Inc.
Subject of the 8‑K filing
- personKatharyn Field
Outgoing CEO
- personShahin Behroyan
Incoming CEO


